Search research articles

联系我们

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

隐私政策

政策

Search research articles

联系我们

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

隐私政策

政策

Search research articles

冠状动脉血栓溶解对于老年人?

J H Gurwitz¹, R J Goldberg, J M Gore

¹Department of Medicine, Harvard Medical School, Boston, Mass.

JAMA

|April 3, 1991

概括

No abstract available in PubMed .

相关实验视频

冠状动脉血栓溶解对于老年人?

相关概念视频

Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).

Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes.

The Global Registry of Acute Coronary Events, 1999 to 2009--GRACE.

Adverse pulmonary effects of topical Beta blockers used in the treatment of glaucoma.

Patterns of glaucoma medication use in the elderly: 1980-1990.

Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratification.

相关实验视频

冠状动脉血栓溶解对于老年人?

相关概念视频

相关文章

Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).

Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes.

The Global Registry of Acute Coronary Events, 1999 to 2009--GRACE.

Adverse pulmonary effects of topical Beta blockers used in the treatment of glaucoma.

Patterns of glaucoma medication use in the elderly: 1980-1990.

Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratification.